Intravenous Anesthesia by Targeted Controlled Infusion Versus Inhalational Anesthesia on the Surgical Stress Response

Assiut University

Status and phase: Active, not recruiting; Phase 4

Conditions: Target-controlled Infusion; Total Intravenous Anesthesia; Surgical Stress Response; Inhalational Anesthesia

Treatments: Drug: Target Controlled Infusion; Drug: Sevoflurane; Drug: Target Controlled Infusion and lidocaine

Study type: Interventional

Funder types: Other

Identifiers

NCT06024733

525

Details and patient eligibility

About

This study aims to compare the effect of total Intravenous anesthesia Target-controlled infusion (TIVA-TCI) with inhalational anesthesia on stress response.

Full description

Target-controlled infusion (TCI) techniques have been used to induce and maintain general anesthesia or to provide computer-assisted personalized sedation. Target-controlled infusion (TCI) systems are computer-assisted IV infusion pumps that use pharmacokinetic and pharmacodynamic mathematical modeling to maintain a user-designated target concentration at an effect site (typically the brain).

The clinician enters a desired target concentration for an anesthetic or another agent. The computer calculates the amount of the agent required to achieve the target concentration at the effect site and directs an infusion pump to deliver the calculated boluses or infusions. Therefore, TIVA-TCI allows a more stable hemodynamic profile during surgery, prevents long-acting opioid-induced accumulation and allows rapid recovery from general anesthesia.

Total intravenous anaesthesia (TIVA) regimen with Propofol is a useful anaesthetic technique, effectively controlling responses to tracheal intubation and intense surgical stimulation, while avoiding Inhalational anaesthetics and allowing rapid emergence from anaesthesia .

Enrollment: 90 patients

Sex: All

Ages: 18 to 60 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Patients subjected to lower abdominal cancer surgery.
2. Patients of both sexes
3. body mass index < 35 kg/m2.
4. Age from 18 to 60 years.
5. ASA, I-II.

Exclusion criteria

1. Patients with a history of severe cardiovascular or respiratory disease.
2. Severe hepatic, renal, or neurological diseases.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

90 participants in 3 patient groups

inhalational

Sham Comparator group

Treatment:

Drug: Sevoflurane

Target Controlled Infusion

Active Comparator group

Treatment:

Drug: Target Controlled Infusion

Target Controlled Infusion and lidocaine

Active Comparator group

Treatment:

Drug: Target Controlled Infusion and lidocaine